Incannex Healthcare Limited
Incannex Healthcare Limited (IXHL) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IXHL · as of Sep 30, 2025
Ownership Breakdown
28
Institutional Holders
▲ 16 vs Q2
$1.76M
Total Inst. Value
▲ $1.54M vs Q2
11.48M
Shares Outstanding
freeFloat 87.70%
3.72M
13F Shares Held
▲ 2.69M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IXHL largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ARETE WEALTH ADVISORS, LLC pharmaceutical preparations | 1.18M | 33.73% | 33.73% | $547.00M | Nov 12, 2025 | NEW |
ADVISORSHARES INVESTMENTS LLC pharmaceutical preparations | 471.3K | 13.49% | 13.49% | $218.81M | Nov 5, 2025 | ▲ 127.3K |
VIRTU FINANCIAL LLC pharmaceutical preparations | 402.4K | 11.52% | 11.52% | $187.00M | Nov 14, 2025 | NEW |
ABACUS WEALTH PARTNERS, LLC pharmaceutical preparations | 250.0K | 7.15% | 7.15% | $116.08M | Nov 12, 2025 | NEW |
JANE STREET GROUP, LLC pharmaceutical preparations | 230.4K | 6.59% | 6.59% | $107.00M | Nov 14, 2025 | NEW |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 189.1K | 5.41% | 5.41% | $122.91M | Nov 14, 2025 | NEW |
CITIGROUP INC pharmaceutical preparations | 177.7K | 5.09% | 5.09% | $82.51M | Nov 10, 2025 | ▲ 151.2K |
UBS GROUP AG pharmaceutical preparations | 169.2K | 4.84% | 4.84% | $78.53M | Nov 13, 2025 | ▲ 98.0K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 116.3K | 3.33% | 3.33% | $54.02M | Nov 12, 2025 | NEW |
COMMONWEALTH EQUITY SERVICES, LLC pharmaceutical preparations | 113.5K | 3.25% | 3.25% | $53.00M | Oct 22, 2025 | ▲ 58.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
5
Increased
+486.9K shares18
New Positions
first time holders3
Decreased
−355.2K shares1
Sold Out
fully exitedNet shares change (top 50)
+131.7K
+486.9K / −355.2K
Net new holders
+19
18 new / 1 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IXHL insider trading · insider activity
Source: SEC Form 4
6
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Valentine Troy director | Nov 14, 2025 | Award | 11,302,608 | — | — | 12.00M | Form 4 ↗ |
Clark Robert director | Nov 14, 2025 | Award | 1,686,956 | — | — | 1.79M | Form 4 ↗ |
Widdows Peter director | Nov 14, 2025 | Award | 1,686,956 | — | — | 1.96M | Form 4 ↗ |
Swan Joseph CFO, Treasurer and Secretary | Nov 14, 2025 | Award | 869,565 | — | — | 921.4K | Form 4 ↗ |
Latham Joel CEO and President | Nov 14, 2025 | Award | 22,608,692 | — | — | 24.19M | Form 4 ↗ |
Anastassov George director | Nov 14, 2025 | Award | 1,686,956 | — | — | 2.46M | Form 4 ↗ |
Barbato Luigi M. Chief Medical Officer | Oct 23, 2024 | Award | 100,476 | — | — | 100.5K | Form 4 ↗ |
Valentine Troy director | Dec 21, 2023 | Award | 670,000 | — | — | 699.3K | Form 4 ↗ |
Widdows Peter director | Dec 21, 2023 | Award | 100,000 | — | — | 270.8K | Form 4 ↗ |
Latham Joel CEO and President | Dec 21, 2023 | Award | 1,340,000 | — | — | 1.58M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Incannex Healthcare Limited (IXHL) is primarily owned by institutional investors, who hold approximately 32.4% of total shares outstanding. Company insiders own approximately 12.30%, while retail and public investors account for the remaining 55.34%.
The largest institutional shareholder of Incannex Healthcare Limited is ARETE WEALTH ADVISORS, LLC, holding approximately 1.18 million shares — equal to 33.73% of outstanding shares — as of September 30, 2025.
A total of 28 institutional investors currently hold IXHL stock, with a combined institutional value of approximately $1,760,070 as of the most recent 13F filing period.
Frequently asked questions
IXHL ownershipIncannex Healthcare Limited (IXHL) is primarily owned by institutional investors, who hold approximately 32.4% of shares. The largest shareholder is ARETE WEALTH ADVISORS, LLC with a 33.73% stake. Company insiders hold 12.30%. Data sourced from SEC Form 13F as of September 30, 2025.